☰

Shawn Walsh - Publications

Affiliations: 
2015- Scripps Research Institute, La Jolla, La Jolla, CA, United States 
Tree Info Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tan YX, Peters DS, Walsh SI, Holcomb M, Santos-Martins D, Forli S, Romesberg FE. Initial Analysis of the Arylomycin D Antibiotics. Journal of Natural Products. PMID 32614583 DOI: 10.1021/Acs.Jnatprod.9B01174  0.738
2018 Walsh SI, Peters DS, Smith PA, Craney A, Dix MM, Cravatt BF, Romesberg FE. The inhibition of protein secretion in and sub-MIC effects of arylomycin antibiotics. Antimicrobial Agents and Chemotherapy. PMID 30420476 DOI: 10.1128/Aac.01253-18  0.709
2018 Yeh CH, Walsh SI, Craney A, Tabor MG, Voica AF, Adhikary R, Morris SE, Romesberg FE. Optimization of a β-Lactam Scaffold for Antibacterial Activity via the Inhibition of Bacterial Type I Signal Peptidase. Acs Medicinal Chemistry Letters. 9: 376-380. PMID 29670704 DOI: 10.1021/Acsmedchemlett.8B00064  0.358
2016 Walsh SI, Craney A, Romesberg FE. Not just an antibiotic target: Exploring the role of type I signal peptidase in bacterial virulence. Bioorganic & Medicinal Chemistry. PMID 27769673 DOI: 10.1016/J.Bmc.2016.09.048  0.763
2011 Walsh SP, Severino A, Zhou C, He J, Liang GB, Tan CP, Cao J, Eiermann GJ, Xu L, Salituro G, Howard AD, Mills SG, Yang L. 3-Substituted 3-(4-aryloxyaryl)-propanoic acids as GPR40 agonists. Bioorganic & Medicinal Chemistry Letters. 21: 3390-4. PMID 21514824 DOI: 10.1016/j.bmcl.2011.03.114  0.317
Show low-probability matches.